memantine hydrochloride
NDC 68180-248, memantine hydrochloride, capsule, extended release, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-248
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206028
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-248 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEMANTINE HYDROCHLORIDE21 mg/1
Pharmacologic classes
N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-248-06 | 68180024806 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-248-06) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/24290655-47f3-4042-a977-a832c5161d2cNADAC price for package 68180024806
GET /v1/drugs/nadac/68180024806
Use it
Look up 68180-248 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-248 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-248. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.